Swiss National Bank’s Loxo Oncology, Inc LOXO Stock Holding History

Swiss National Bank’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-40,400	Closed	-$5.66M	–	2524
2018 Q4	$5.66M	Buy	40,400 +1,300	+3%	+$197K	0.01%	915
2018 Q3	$6.68M	Hold	39,100	–	–	0.01%	928
2018 Q2	$6.78M	Buy	39,100 +2,700	+7%	+$406K	0.01%	909
2018 Q1	$4.2M	Buy	36,400 +700	+2%	+$74.5K	0.01%	1149
2017 Q4	$3M	Hold	35,700	–	–	﹤0.01%	1388
2017 Q3	$3.29M	Hold	35,700	–	–	﹤0.01%	1307
2017 Q2	$2.86M	Buy	35,700 +7,000	+24%	+$388K	﹤0.01%	1353
2017 Q1	$1.21M	Buy	28,700 +10,000	+53%	+$412K	﹤0.01%	1899
2016 Q4	$601K	Hold	18,700	–	–	﹤0.01%	2312
2016 Q3	$490K	Sell	18,700 -1,500	-7%	-$39.2K	﹤0.01%	2361
2016 Q2	$468K	Buy	+20,200	New	+$503K	﹤0.01%	2384

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Swiss National Bank's LOXO Position: Q1 2019 in Review

Swiss National Bank sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 40,400 shares — an estimated $5.66M sold.

Swiss National Bank first reported a position in LOXO in Q2 2016 and held it in 11 quarters. The position peaked at $6.78M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Swiss National Bank reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Swiss National Bank sold 40,400 Loxo Oncology, Inc shares in Q1 2019, an estimated $5.66M.
Swiss National Bank first reported a position in Loxo Oncology, Inc in Q2 2016 and held it in 11 quarters.
Swiss National Bank's Loxo Oncology, Inc position peaked at $6.78M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Swiss National Bank's 13F filing for Q1 2019, filed 10 May 2019.